StockGuru Leader Board: ChemoCentryx, Inc. (NASDAQ: CCXI) Closed Up 11.27% on Tuesday

ChemoCentryx, Inc. (NASDAQ: CCXI) is on The StockGuru Leader Board today.  The stock closed up 11.27% on Tuesday.

Volume was 31,574 shares traded.

Join in on the Discussion about CCXI

About the Company:

ChemoCentryx, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, designing, developing, and commercializing orally-administrated small molecule therapeutics in the United States. Its small molecule therapeutics target chemokine receptors and related chemo-attractant receptors in order to treat autoimmune diseases, inflammatory disorders, and cancer. The company develops Traficet-EN, an anti-inflammatory small molecule therapeutic that targets the CCR9 chemokine receptor, as well as for the treatment of patients with moderate-to-severe Crohn’s and celiac diseases; and CCX140, a CCR2 inhibitor for the treatment of diabetic kidney disease (diabetic nephropathy). ChemoCentryx, Inc. has a strategic alliance with Glaxo Group, Ltd. The company was founded in 1997 and is headquartered in Mountain View, California.

About the StockGuru Leader Board:

We watch for stocks moving up and creating a positive momentum in the market.  We are not compensated for coverage.

Feel free to suggest a stock for coverage if you see it breaking out.  Contact:
IR Affiliates –
StoneBridge Web & SEO –

All content on is original content – with the exception of client news releases. All content is (C) Copyright 2002 to 2012 StockGuru. No content may be used in whole or in part without the express written consent of our Publisher. We encourage web sites interested in our content to offer a reciprocal exchange agreement in exchange for use of some of our content. We do not offer advance approval, but contact our Publisher if you have an interest in repropagating our content. Contact as at: or (469) 252-3030. Mailing address: 1601 Berwick Drive; McKinney, Texas 75070